Evidence map›Paper›PMID 24244750›Full record

ArticlePloS one2013

Increased basal and alum-induced interleukin-6 levels in geriatric patients are associated with cardiovascular morbidity.

Nathalie Compté, Karim Zouaoui Boudjeltia, Michel Vanhaeverbeek, Sandra De Breucker, Thierry Pepersack, Joel Tassignon, Anne Trelcat, Stanislas Goriely

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nathalie ComptéInstitute for Medical Immunology (IMI), Université Libre de Bruxelles, Charleroi, Belgium.
Karim Zouaoui Boudjeltia
Michel Vanhaeverbeek
Sandra De Breucker
Thierry Pepersack
Joel Tassignon
Anne Trelcat
Stanislas Goriely
Université Libre de Bruxelles · BEErasmus Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/aim of the studyLow-grade systemic inflammation was suggested to participate to the decline of physiological functions and increased vulnerability encountered in older patients. Geriatric syndromes encompass various features such as functional dependence, polymorbidity, depression and malnutrition. There is a strong prevalence of cardiovascular diseases and related risk factors and chronic cytomegalovirus infections in the geriatric population. As these underlying conditions were proposed to influence the inflammatory state, the aim of this study was to assess their potential contribution to the association of geriatric syndromes with inflammatory parameters. METHODOLOGY: We recruited 100 subjects in the general population or hospitalized for chronic medical conditions (age, 23-96 years). We collected information on clinical status (medical history, ongoing comorbidities, treatments and geriatric scales), biological parameters (hematological tests, cytomegalovirus serology) and cytokines production (basal and alum-induced interleukin (IL)-1β and IL-6 levels). Using stepwise backward multivariate analyses, we defined which set of clinical and biological variables could be predictive for increased inflammatory markers. PRINCIPAL

findingsWe confirmed the age-associated increase of circulating IL-6 levels. In contrast to geriatric scales, we found history of cardiovascular diseases to be strongly associated for this parameter as for high IL-6 production upon ex vivo stimulation with alum.

conclusionsAssociation between low-grade inflammation and geriatric conditions could be linked to underlying cardiovascular diseases.

Indexed as

AdultAgedAged, 80 and overAlum CompoundsCardiovascular DiseasesFemaleHumansInflammationInterleukin-1Interleukin-6MaleMiddle AgedRisk FactorsTumor Necrosis Factor-alphaYoung AdultAlum Compoundsaluminum sulfateInterleukin-1Interleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID24244750
PMCPMC3828251
OpenAlexW2045824414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.